InMed Pharmaceuticals Inc. filed a Form 425 communication on November 2, 2026, announcing a planned 10-for-1 share consolidation of its Common Shares in connection with the proposed merger involving Mentari Therapeutics, Inc.
Gregory T. Moskoff, MD, Controller and CAO of FactSet Research Systems Inc., filed a Form 4 on November 2, 2026, disclosing the vesting of performance share units and a related tax withholding transaction on November 1, 2026.
Director David Pauldine filed a Form 4 with the SEC on November 2, 2026, disclosing the acquisition of 8,459 shares of QuinStreet, Inc. common stock through a Restricted Stock Unit award dated October 29, 2026, listed on NASDAQ:QNST.
Director Asmau Ahmed filed a Form 4 with the SEC on November 2, 2026, disclosing the acquisition of 8,459 shares of QuinStreet, Inc. common stock through a Restricted Stock Unit award dated October 29, 2026.
Director Stuart Huizinga of QuinStreet, Inc. filed a Form 4 on November 2, 2026, disclosing the acquisition of 8,459 shares of common stock through a Restricted Stock Unit award with a transaction date of October 29, 2026.
Director Andrew T. Sheehan of QuinStreet, Inc. filed a Form 4 on November 2, 2026, reporting transactions in the company's common stock dated October 29, 2026, including the acquisition of 8,459 shares through a Restricted Stock Unit award and the gift transfer of 9,938 …
Angelique M. Okeke, Executive Vice President and General Counsel of F5, Inc., filed a statement of changes in beneficial ownership on November 2, 2026, reporting the acquisition of 1,366 shares of common stock on October 29, 2026.
Director James R. Simons filed a Form 4 with the SEC on November 2, 2026, reporting the acquisition of 8,459 shares of QuinStreet, Inc. common stock through a Restricted Stock Unit award dated October 29, 2026.
Director Hillary B. Smith filed a Form 4 with the SEC on November 2, 2026, reporting the acquisition of 8,459 shares of QuinStreet, Inc. common stock through a Restricted Stock Unit award dated October 29, 2026.
Thomas Dean Fountain, Executive Vice President of Global Services and Strategy at F5, Inc., filed a Form 4 on November 2, 2026, disclosing the acquisition of 18,275 shares of common stock on October 29, 2026, stemming from performance-based vesting of Restricted Stock Units.